Principal Investigator
John Krystal, MD
Yale University
- 3 trials
- 1 recruiting now
- 1 compound
Therapeutic focus
- Depressive Disorder, Major
- Post Traumatic Stress Disorder
- Early Course Schizophrenia Spectrum Disorder
- Bipolar Disorder
Recruiting now (1)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT05915013 | Phase 1 | Recruiting | — | Yale University |
All trials (3)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT05915013 | Phase 1 | Recruiting | — | Yale University |
| NCT04457310 | Phase 2 | Completed | PF-06412562 (CVL-562) | Yale University |
| NCT03367533 | Phase 1 | Completed | — | Yale University |
Compounds studied
Trial sites (4)
- New Haven, Connecticut, United States
- New York, New York, United States
- Stony Brook, New York, United States
- Philadelphia, Pennsylvania, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).